APO Research
Talk to an analyst

APO RESEARCH · REPORT

Site-directed Mutagenesis Service

Compare research editions
View pricing & licenses

Selected research

Industry Research

Site-directed Mutagenesis Service Industry Research Report 2026

12 August 2026137 pages

Choose your research edition.

Industry ResearchSite-directed Mutagenesis Service Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Site-directed Mutagenesis Service Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Site-directed Mutagenesis Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Site-directed Mutagenesis Service Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Site-directed Mutagenesis Service Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Site-directed Mutagenesis Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Site-directed Mutagenesis Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Site-directed Mutagenesis Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Site-directed Mutagenesis Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Site-directed Mutagenesis Service include Azenta Life Sciences, Thermo Fisher Scientific, Bon Opus Biosciences, Charles Rive, Creative Biogene, Synbio Technologies, Creative Biolabs, NovoPro and Bionexus, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Site-directed Mutagenesis Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Site-directed Mutagenesis Service.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Site-directed Mutagenesis Service Market by Company

Azenta Life Sciences

Thermo Fisher Scientific

Bon Opus Biosciences

Charles Rive

Creative Biogene

Synbio Technologies

Creative Biolabs

NovoPro

Bionexus

Biotech Desk

NorClone

Eton Bioscience

Syd Labs

Genosphere Biotechnologies

WZ Biosciences

FulenGen

GENEWIZ

iGene Biotechnology

Tsingke

AtaGenix

Zoonbio Biotechnology

GenScript

Eurofins

Applied Biological Materials

Site-directed Mutagenesis Service Segment by Type

Standard Site-directed Mutagenesis Service

Customized Site-directed Mutagenesis Service

Site-directed Mutagenesis Service Segment by Application

Scientific Research

Gene Therapy

Cell Therapy

Others

Site-directed Mutagenesis Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Site-directed Mutagenesis Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Site-directed Mutagenesis Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Site-directed Mutagenesis Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Site-directed Mutagenesis Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Site-directed Mutagenesis Service Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Site-directed Mutagenesis Service Revenue Market Share by Type (2021-2026) Table 7. Global Site-directed Mutagenesis Service Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Site-directed Mutagenesis Service Revenue Market Share by Type (2027-2032) Table 9. Global Site-directed Mutagenesis Service Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Site-directed Mutagenesis Service Revenue Market Share by Application (2021-2026) Table 11. Global Site-directed Mutagenesis Service Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Site-directed Mutagenesis Service Revenue Market Share by Application (2027-2032) Table 13. Global Site-directed Mutagenesis Service Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Site-directed Mutagenesis Service Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Site-directed Mutagenesis Service Market Share by Region (2021-2026) Table 16. Global Site-directed Mutagenesis Service Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Site-directed Mutagenesis Service Market Share by Region (2027-2032) Table 18. Site-directed Mutagenesis Service Industry Trends Table 19. Site-directed Mutagenesis Service Industry Drivers Table 20. Site-directed Mutagenesis Service Industry Opportunities and Challenges Table 21. Site-directed Mutagenesis Service Market Restraints Table 22. Global Top Site-directed Mutagenesis Service Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Site-directed Mutagenesis Service Revenue Market Share by Players (2021-2026) Table 24. Global Site-directed Mutagenesis Service Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Site-directed Mutagenesis Service, Headquarters and Area Served Table 26. Global Site-directed Mutagenesis Service Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Site-directed Mutagenesis Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Site-directed Mutagenesis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Site-directed Mutagenesis Service Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Site-directed Mutagenesis Service Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Site-directed Mutagenesis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Site-directed Mutagenesis Service Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Site-directed Mutagenesis Service Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Site-directed Mutagenesis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Site-directed Mutagenesis Service Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Site-directed Mutagenesis Service Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Site-directed Mutagenesis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Site-directed Mutagenesis Service Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Site-directed Mutagenesis Service Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Site-directed Mutagenesis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Site-directed Mutagenesis Service Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Site-directed Mutagenesis Service Market Size by Country (2027-2032) & (US$ Million) Table 45. Azenta Life Sciences Company Information Table 46. Azenta Life Sciences Business Overview Table 47. Azenta Life Sciences Revenue in Site-directed Mutagenesis Service Business (2021-2026) & (US$ Million) Table 48. Azenta Life Sciences Site-directed Mutagenesis Service Product Portfolio Table 49. Azenta Life Sciences Recent Developments Table 50. Thermo Fisher Scientific Company Information Table 51. Thermo Fisher Scientific Business Overview Table 52. Thermo Fisher Scientific Revenue in Site-directed Mutagenesis Service Business (2021-2026) & (US$ Million) Table 53. Thermo Fisher Scientific Site-directed Mutagenesis Service Product Portfolio Table 54. Thermo Fisher Scientific Recent Developments Table 55. Bon Opus Biosciences Company Information Table 56. Bon Opus Biosciences Business Overview Table 57. Bon Opus Biosciences Revenue in Site-directed Mutagenesis Service Business (2021-2026) & (US$ Million) Table 58. Bon Opus Biosciences Site-directed Mutagenesis Service Product Portfolio Table 59. Bon Opus Biosciences Recent Developments Table 60. Charles Rive Company Information Table 61. Charles Rive Business Overview Table 62. Charles Rive Revenue in Site-directed Mutagenesis Service Business (2021-2026) & (US$ Million) Table 63. Charles Rive Site-directed Mutagenesis Service Product Portfolio Table 64. Charles Rive Recent Developments Table 65. Creative Biogene Company Information Table 66. Creative Biogene Business Overview Table 67. Creative Biogene Revenue in Site-directed Mutagenesis Service Business (2021-2026) & (US$ Million) Table 68. Creative Biogene Site-directed Mutagenesis Service Product Portfolio Table 69. Creative Biogene Recent Developments Table 70. Synbio Technologies Company Information Table 71. Synbio Technologies Business Overview Table 72. Synbio Technologies Revenue in Site-directed Mutagenesis Service Business (2021-2026) & (US$ Million) Table 73. Synbio Technologies Site-directed Mutagenesis Service Product Portfolio Table 74. Synbio Technologies Recent Developments Table 75. Creative Biolabs Company Information Table 76. Creative Biolabs Business Overview Table 77. Creative Biolabs Revenue in Site-directed Mutagenesis Service Business (2021-2026) & (US$ Million) Table 78. Creative Biolabs Site-directed Mutagenesis Service Product Portfolio Table 79. Creative Biolabs Recent Developments Table 80. NovoPro Company Information Table 81. NovoPro Business Overview Table 82. NovoPro Revenue in Site-directed Mutagenesis Service Business (2021-2026) & (US$ Million) Table 83. NovoPro Site-directed Mutagenesis Service Product Portfolio Table 84. NovoPro Recent Developments Table 85. Bionexus Company Information Table 86. Bionexus Business Overview Table 87. Bionexus Revenue in Site-directed Mutagenesis Service Business (2021-2026) & (US$ Million) Table 88. Bionexus Site-directed Mutagenesis Service Product Portfolio Table 89. Bionexus Recent Developments Table 90. Biotech Desk Company Information Table 91. Biotech Desk Business Overview Table 92. Biotech Desk Revenue in Site-directed Mutagenesis Service Business (2021-2026) & (US$ Million) Table 93. Biotech Desk Site-directed Mutagenesis Service Product Portfolio Table 94. Biotech Desk Recent Developments Table 95. NorClone Company Information Table 96. NorClone Business Overview Table 97. NorClone Revenue in Site-directed Mutagenesis Service Business (2021-2026) & (US$ Million) Table 98. NorClone Site-directed Mutagenesis Service Product Portfolio Table 99. NorClone Recent Developments Table 100. Eton Bioscience Company Information Table 101. Eton Bioscience Business Overview Table 102. Eton Bioscience Revenue in Site-directed Mutagenesis Service Business (2021-2026) & (US$ Million) Table 103. Eton Bioscience Site-directed Mutagenesis Service Product Portfolio Table 104. Eton Bioscience Recent Developments Table 105. Syd Labs Company Information Table 106. Syd Labs Business Overview Table 107. Syd Labs Revenue in Site-directed Mutagenesis Service Business (2021-2026) & (US$ Million) Table 108. Syd Labs Site-directed Mutagenesis Service Product Portfolio Table 109. Syd Labs Recent Developments Table 110. Genosphere Biotechnologies Company Information Table 111. Genosphere Biotechnologies Business Overview Table 112. Genosphere Biotechnologies Revenue in Site-directed Mutagenesis Service Business (2021-2026) & (US$ Million) Table 113. Genosphere Biotechnologies Site-directed Mutagenesis Service Product Portfolio Table 114. Genosphere Biotechnologies Recent Developments Table 115. WZ Biosciences Company Information Table 116. WZ Biosciences Business Overview Table 117. WZ Biosciences Revenue in Site-directed Mutagenesis Service Business (2021-2026) & (US$ Million) Table 118. WZ Biosciences Site-directed Mutagenesis Service Product Portfolio Table 119. WZ Biosciences Recent Developments Table 120. FulenGen Company Information Table 121. FulenGen Business Overview Table 122. FulenGen Revenue in Site-directed Mutagenesis Service Business (2021-2026) & (US$ Million) Table 123. FulenGen Site-directed Mutagenesis Service Product Portfolio Table 124. FulenGen Recent Developments Table 125. GENEWIZ Company Information Table 126. GENEWIZ Business Overview Table 127. GENEWIZ Revenue in Site-directed Mutagenesis Service Business (2021-2026) & (US$ Million) Table 128. GENEWIZ Site-directed Mutagenesis Service Product Portfolio Table 129. GENEWIZ Recent Developments Table 130. iGene Biotechnology Company Information Table 131. iGene Biotechnology Business Overview Table 132. iGene Biotechnology Revenue in Site-directed Mutagenesis Service Business (2021-2026) & (US$ Million) Table 133. iGene Biotechnology Site-directed Mutagenesis Service Product Portfolio Table 134. iGene Biotechnology Recent Developments Table 135. Tsingke Company Information Table 136. Tsingke Business Overview Table 137. Tsingke Revenue in Site-directed Mutagenesis Service Business (2021-2026) & (US$ Million) Table 138. Tsingke Site-directed Mutagenesis Service Product Portfolio Table 139. Tsingke Recent Developments Table 140. AtaGenix Company Information Table 141. AtaGenix Business Overview Table 142. AtaGenix Revenue in Site-directed Mutagenesis Service Business (2021-2026) & (US$ Million) Table 143. AtaGenix Site-directed Mutagenesis Service Product Portfolio Table 144. AtaGenix Recent Developments Table 145. Zoonbio Biotechnology Company Information Table 146. Zoonbio Biotechnology Business Overview Table 147. Zoonbio Biotechnology Revenue in Site-directed Mutagenesis Service Business (2021-2026) & (US$ Million) Table 148. Zoonbio Biotechnology Site-directed Mutagenesis Service Product Portfolio Table 149. Zoonbio Biotechnology Recent Developments Table 150. GenScript Company Information Table 151. GenScript Business Overview Table 152. GenScript Revenue in Site-directed Mutagenesis Service Business (2021-2026) & (US$ Million) Table 153. GenScript Site-directed Mutagenesis Service Product Portfolio Table 154. GenScript Recent Developments Table 155. Eurofins Company Information Table 156. Eurofins Business Overview Table 157. Eurofins Revenue in Site-directed Mutagenesis Service Business (2021-2026) & (US$ Million) Table 158. Eurofins Site-directed Mutagenesis Service Product Portfolio Table 159. Eurofins Recent Developments Table 160. Applied Biological Materials Company Information Table 161. Applied Biological Materials Business Overview Table 162. Applied Biological Materials Revenue in Site-directed Mutagenesis Service Business (2021-2026) & (US$ Million) Table 163. Applied Biological Materials Site-directed Mutagenesis Service Product Portfolio Table 164. Applied Biological Materials Recent Developments Table 165. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Site-directed Mutagenesis Service Product Image Figure 5. Global Site-directed Mutagenesis Service Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Site-directed Mutagenesis Service Market Share by Type: 2025 VS 2032 Figure 7. Standard Site-directed Mutagenesis Service Product Figure 8. Customized Site-directed Mutagenesis Service Product Figure 9. Global Site-directed Mutagenesis Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Site-directed Mutagenesis Service Market Share by Application: 2025 VS 2032 Figure 11. Scientific Research Product Figure 12. Gene Therapy Product Figure 13. Cell Therapy Product Figure 14. Others Product Figure 15. Global Site-directed Mutagenesis Service Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 16. Global Site-directed Mutagenesis Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Site-directed Mutagenesis Service Market Share by Region: 2025 VS 2032 Figure 18. Global Site-directed Mutagenesis Service Market Share by Players in 2025 Figure 19. Global Site-directed Mutagenesis Service Manufacturers Established Date Figure 20. Global Top 5 and 10 Site-directed Mutagenesis Service Players Market Share by Revenue in 2025 Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. North America Site-directed Mutagenesis Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Site-directed Mutagenesis Service Market Share by Country (2021-2032) Figure 24. United States Site-directed Mutagenesis Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Canada Site-directed Mutagenesis Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Mexico Site-directed Mutagenesis Service Market Share by Country (2021-2032) Figure 27. Europe Site-directed Mutagenesis Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 28. Europe Site-directed Mutagenesis Service Market Share by Country (2021-2032) Figure 29. Germany Site-directed Mutagenesis Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. France Site-directed Mutagenesis Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. U.K. Site-directed Mutagenesis Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. Italy Site-directed Mutagenesis Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Spain Site-directed Mutagenesis Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Russia Site-directed Mutagenesis Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Netherlands Site-directed Mutagenesis Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Nordic Countries Site-directed Mutagenesis Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Site-directed Mutagenesis Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Site-directed Mutagenesis Service Market Share by Country (2021-2032) Figure 39. China Site-directed Mutagenesis Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. Japan Site-directed Mutagenesis Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. South Korea Site-directed Mutagenesis Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. India Site-directed Mutagenesis Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. India Site-directed Mutagenesis Service Market Share by Country (2021-2032) Figure 44. Australia Site-directed Mutagenesis Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. China Taiwan Site-directed Mutagenesis Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. Southeast Asia Site-directed Mutagenesis Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. South America Site-directed Mutagenesis Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. South America Site-directed Mutagenesis Service Market Share by Country (2021-2032) Figure 49. Brazil Site-directed Mutagenesis Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. Argentina Site-directed Mutagenesis Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Chile Site-directed Mutagenesis Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Colombia Site-directed Mutagenesis Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Peru Site-directed Mutagenesis Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. Azenta Life Sciences Revenue Growth Rate in Site-directed Mutagenesis Service Business (2021-2026) Figure 55. Thermo Fisher Scientific Revenue Growth Rate in Site-directed Mutagenesis Service Business (2021-2026) Figure 56. Bon Opus Biosciences Revenue Growth Rate in Site-directed Mutagenesis Service Business (2021-2026) Figure 57. Charles Rive Revenue Growth Rate in Site-directed Mutagenesis Service Business (2021-2026) Figure 58. Creative Biogene Revenue Growth Rate in Site-directed Mutagenesis Service Business (2021-2026) Figure 59. Synbio Technologies Revenue Growth Rate in Site-directed Mutagenesis Service Business (2021-2026) Figure 60. Creative Biolabs Revenue Growth Rate in Site-directed Mutagenesis Service Business (2021-2026) Figure 61. NovoPro Revenue Growth Rate in Site-directed Mutagenesis Service Business (2021-2026) Figure 62. Bionexus Revenue Growth Rate in Site-directed Mutagenesis Service Business (2021-2026) Figure 63. Biotech Desk Revenue Growth Rate in Site-directed Mutagenesis Service Business (2021-2026) Figure 64. NorClone Revenue Growth Rate in Site-directed Mutagenesis Service Business (2021-2026) Figure 65. Eton Bioscience Revenue Growth Rate in Site-directed Mutagenesis Service Business (2021-2026) Figure 66. Syd Labs Revenue Growth Rate in Site-directed Mutagenesis Service Business (2021-2026) Figure 67. Genosphere Biotechnologies Revenue Growth Rate in Site-directed Mutagenesis Service Business (2021-2026) Figure 68. WZ Biosciences Revenue Growth Rate in Site-directed Mutagenesis Service Business (2021-2026) Figure 69. FulenGen Revenue Growth Rate in Site-directed Mutagenesis Service Business (2021-2026) Figure 70. GENEWIZ Revenue Growth Rate in Site-directed Mutagenesis Service Business (2021-2026) Figure 71. iGene Biotechnology Revenue Growth Rate in Site-directed Mutagenesis Service Business (2021-2026) Figure 72. Tsingke Revenue Growth Rate in Site-directed Mutagenesis Service Business (2021-2026) Figure 73. AtaGenix Revenue Growth Rate in Site-directed Mutagenesis Service Business (2021-2026) Figure 74. Zoonbio Biotechnology Revenue Growth Rate in Site-directed Mutagenesis Service Business (2021-2026) Figure 75. GenScript Revenue Growth Rate in Site-directed Mutagenesis Service Business (2021-2026) Figure 76. Eurofins Revenue Growth Rate in Site-directed Mutagenesis Service Business (2021-2026) Figure 77. Applied Biological Materials Revenue Growth Rate in Site-directed Mutagenesis Service Business (2021-2026)

Scope & coverage.

Types
  • Standard Site-directed Mutagenesis Service
  • Customized Site-directed Mutagenesis Service
Applications
  • Scientific Research
  • Gene Therapy
  • Cell Therapy
  • Others
Companies covered
  • Azenta Life Sciences
  • Thermo Fisher Scientific
  • Bon Opus Biosciences
  • Charles Rive
  • Creative Biogene
  • Synbio Technologies
  • Creative Biolabs
  • NovoPro
  • Bionexus
  • Biotech Desk
  • NorClone
  • Eton Bioscience
  • Syd Labs
  • Genosphere Biotechnologies
  • WZ Biosciences
  • FulenGen
  • GENEWIZ
  • iGene Biotechnology
  • Tsingke
  • AtaGenix
  • Zoonbio Biotechnology
  • GenScript
  • Eurofins
  • Applied Biological Materials

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Site-directed Mutagenesis Service by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 Standard Site-directed Mutagenesis Service
  5. 2.2.3 Customized Site-directed Mutagenesis Service
  6. 2.3 Site-directed Mutagenesis Service by Application
  7. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  8. 2.3.2 Scientific Research
  9. 2.3.3 Gene Therapy
  10. 2.3.4 Cell Therapy
  11. 2.3.5 Others
  12. 2.4 Assumptions and Limitations
3 Site-directed Mutagenesis Service Breakdown Data by Type
  1. 3.1 Global Site-directed Mutagenesis Service Historic Market Size by Type (2021-2026)
  2. 3.2 Global Site-directed Mutagenesis Service Forecasted Market Size by Type (2027-2032)
4 Site-directed Mutagenesis Service Breakdown Data by Application
  1. 4.1 Global Site-directed Mutagenesis Service Historic Market Size by Application (2021-2026)
  2. 4.2 Global Site-directed Mutagenesis Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Site-directed Mutagenesis Service Market Perspective (2021-2032)
  2. 5.2 Global Site-directed Mutagenesis Service Growth Trends by Region
  3. 5.2.1 Global Site-directed Mutagenesis Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Site-directed Mutagenesis Service Historic Market Size by Region (2021-2026)
  5. 5.2.3 Site-directed Mutagenesis Service Forecasted Market Size by Region (2027-2032)
  6. 5.3 Site-directed Mutagenesis Service Market Dynamics
  7. 5.3.1 Site-directed Mutagenesis Service Industry Trends
  8. 5.3.2 Site-directed Mutagenesis Service Market Drivers
  9. 5.3.3 Site-directed Mutagenesis Service Market Challenges
  10. 5.3.4 Site-directed Mutagenesis Service Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Site-directed Mutagenesis Service Players by Revenue
  2. 6.1.1 Global Top Site-directed Mutagenesis Service Players by Revenue (2021-2026)
  3. 6.1.2 Global Site-directed Mutagenesis Service Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Site-directed Mutagenesis Service Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Site-directed Mutagenesis Service Head Office and Area Served
  6. 6.4 Global Site-directed Mutagenesis Service Players, Product Type & Application
  7. 6.5 Global Site-directed Mutagenesis Service Manufacturers Established Date
  8. 6.6 Global Site-directed Mutagenesis Service Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Site-directed Mutagenesis Service Market Size (2021-2032)
  2. 7.2 North America Site-directed Mutagenesis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Site-directed Mutagenesis Service Market Size by Country (2021-2026)
  4. 7.4 North America Site-directed Mutagenesis Service Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Site-directed Mutagenesis Service Market Size (2021-2032)
  2. 8.2 Europe Site-directed Mutagenesis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Site-directed Mutagenesis Service Market Size by Country (2021-2026)
  4. 8.4 Europe Site-directed Mutagenesis Service Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Site-directed Mutagenesis Service Market Size (2021-2032)
  2. 9.2 Asia-Pacific Site-directed Mutagenesis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Site-directed Mutagenesis Service Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Site-directed Mutagenesis Service Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Site-directed Mutagenesis Service Market Size (2021-2032)
  2. 10.2 South America Site-directed Mutagenesis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Site-directed Mutagenesis Service Market Size by Country (2021-2026)
  4. 10.4 South America Site-directed Mutagenesis Service Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Site-directed Mutagenesis Service Market Size (2021-2032)
  2. 11.2 Middle East & Africa Site-directed Mutagenesis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Site-directed Mutagenesis Service Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Site-directed Mutagenesis Service Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 Azenta Life Sciences
  2. 12.1.1 Azenta Life Sciences Company Information
  3. 12.1.2 Azenta Life Sciences Business Overview
  4. 12.1.3 Azenta Life Sciences Revenue in Site-directed Mutagenesis Service Business (2021-2026)
  5. 12.1.4 Azenta Life Sciences Site-directed Mutagenesis Service Product Portfolio
  6. 12.1.5 Azenta Life Sciences Recent Developments
  7. 12.2 Thermo Fisher Scientific
  8. 12.2.1 Thermo Fisher Scientific Company Information
  9. 12.2.2 Thermo Fisher Scientific Business Overview
  10. 12.2.3 Thermo Fisher Scientific Revenue in Site-directed Mutagenesis Service Business (2021-2026)
  11. 12.2.4 Thermo Fisher Scientific Site-directed Mutagenesis Service Product Portfolio
  12. 12.2.5 Thermo Fisher Scientific Recent Developments
  13. 12.3 Bon Opus Biosciences
  14. 12.3.1 Bon Opus Biosciences Company Information
  15. 12.3.2 Bon Opus Biosciences Business Overview
  16. 12.3.3 Bon Opus Biosciences Revenue in Site-directed Mutagenesis Service Business (2021-2026)
  17. 12.3.4 Bon Opus Biosciences Site-directed Mutagenesis Service Product Portfolio
  18. 12.3.5 Bon Opus Biosciences Recent Developments
  19. 12.4 Charles Rive
  20. 12.4.1 Charles Rive Company Information
  21. 12.4.2 Charles Rive Business Overview
  22. 12.4.3 Charles Rive Revenue in Site-directed Mutagenesis Service Business (2021-2026)
  23. 12.4.4 Charles Rive Site-directed Mutagenesis Service Product Portfolio
  24. 12.4.5 Charles Rive Recent Developments
  25. 12.5 Creative Biogene
  26. 12.5.1 Creative Biogene Company Information
  27. 12.5.2 Creative Biogene Business Overview
  28. 12.5.3 Creative Biogene Revenue in Site-directed Mutagenesis Service Business (2021-2026)
  29. 12.5.4 Creative Biogene Site-directed Mutagenesis Service Product Portfolio
  30. 12.5.5 Creative Biogene Recent Developments
  31. 12.6 Synbio Technologies
  32. 12.6.1 Synbio Technologies Company Information
  33. 12.6.2 Synbio Technologies Business Overview
  34. 12.6.3 Synbio Technologies Revenue in Site-directed Mutagenesis Service Business (2021-2026)
  35. 12.6.4 Synbio Technologies Site-directed Mutagenesis Service Product Portfolio
  36. 12.6.5 Synbio Technologies Recent Developments
  37. 12.7 Creative Biolabs
  38. 12.7.1 Creative Biolabs Company Information
  39. 12.7.2 Creative Biolabs Business Overview
  40. 12.7.3 Creative Biolabs Revenue in Site-directed Mutagenesis Service Business (2021-2026)
  41. 12.7.4 Creative Biolabs Site-directed Mutagenesis Service Product Portfolio
  42. 12.7.5 Creative Biolabs Recent Developments
  43. 12.8 NovoPro
  44. 12.8.1 NovoPro Company Information
  45. 12.8.2 NovoPro Business Overview
  46. 12.8.3 NovoPro Revenue in Site-directed Mutagenesis Service Business (2021-2026)
  47. 12.8.4 NovoPro Site-directed Mutagenesis Service Product Portfolio
  48. 12.8.5 NovoPro Recent Developments
  49. 12.9 Bionexus
  50. 12.9.1 Bionexus Company Information
  51. 12.9.2 Bionexus Business Overview
  52. 12.9.3 Bionexus Revenue in Site-directed Mutagenesis Service Business (2021-2026)
  53. 12.9.4 Bionexus Site-directed Mutagenesis Service Product Portfolio
  54. 12.9.5 Bionexus Recent Developments
  55. 12.10 Biotech Desk
  56. 12.10.1 Biotech Desk Company Information
  57. 12.10.2 Biotech Desk Business Overview
  58. 12.10.3 Biotech Desk Revenue in Site-directed Mutagenesis Service Business (2021-2026)
  59. 12.10.4 Biotech Desk Site-directed Mutagenesis Service Product Portfolio
  60. 12.10.5 Biotech Desk Recent Developments
  61. 12.11 NorClone
  62. 12.11.1 NorClone Company Information
  63. 12.11.2 NorClone Business Overview
  64. 12.11.3 NorClone Revenue in Site-directed Mutagenesis Service Business (2021-2026)
  65. 12.11.4 NorClone Site-directed Mutagenesis Service Product Portfolio
  66. 12.11.5 NorClone Recent Developments
  67. 12.12 Eton Bioscience
  68. 12.12.1 Eton Bioscience Company Information
  69. 12.12.2 Eton Bioscience Business Overview
  70. 12.12.3 Eton Bioscience Revenue in Site-directed Mutagenesis Service Business (2021-2026)
  71. 12.12.4 Eton Bioscience Site-directed Mutagenesis Service Product Portfolio
  72. 12.12.5 Eton Bioscience Recent Developments
  73. 12.13 Syd Labs
  74. 12.13.1 Syd Labs Company Information
  75. 12.13.2 Syd Labs Business Overview
  76. 12.13.3 Syd Labs Revenue in Site-directed Mutagenesis Service Business (2021-2026)
  77. 12.13.4 Syd Labs Site-directed Mutagenesis Service Product Portfolio
  78. 12.13.5 Syd Labs Recent Developments
  79. 12.14 Genosphere Biotechnologies
  80. 12.14.1 Genosphere Biotechnologies Company Information
  81. 12.14.2 Genosphere Biotechnologies Business Overview
  82. 12.14.3 Genosphere Biotechnologies Revenue in Site-directed Mutagenesis Service Business (2021-2026)
  83. 12.14.4 Genosphere Biotechnologies Site-directed Mutagenesis Service Product Portfolio
  84. 12.14.5 Genosphere Biotechnologies Recent Developments
  85. 12.15 WZ Biosciences
  86. 12.15.1 WZ Biosciences Company Information
  87. 12.15.2 WZ Biosciences Business Overview
  88. 12.15.3 WZ Biosciences Revenue in Site-directed Mutagenesis Service Business (2021-2026)
  89. 12.15.4 WZ Biosciences Site-directed Mutagenesis Service Product Portfolio
  90. 12.15.5 WZ Biosciences Recent Developments
  91. 12.16 FulenGen
  92. 12.16.1 FulenGen Company Information
  93. 12.16.2 FulenGen Business Overview
  94. 12.16.3 FulenGen Revenue in Site-directed Mutagenesis Service Business (2021-2026)
  95. 12.16.4 FulenGen Site-directed Mutagenesis Service Product Portfolio
  96. 12.16.5 FulenGen Recent Developments
  97. 12.17 GENEWIZ
  98. 12.17.1 GENEWIZ Company Information
  99. 12.17.2 GENEWIZ Business Overview
  100. 12.17.3 GENEWIZ Revenue in Site-directed Mutagenesis Service Business (2021-2026)
  101. 12.17.4 GENEWIZ Site-directed Mutagenesis Service Product Portfolio
  102. 12.17.5 GENEWIZ Recent Developments
  103. 12.18 iGene Biotechnology
  104. 12.18.1 iGene Biotechnology Company Information
  105. 12.18.2 iGene Biotechnology Business Overview
  106. 12.18.3 iGene Biotechnology Revenue in Site-directed Mutagenesis Service Business (2021-2026)
  107. 12.18.4 iGene Biotechnology Site-directed Mutagenesis Service Product Portfolio
  108. 12.18.5 iGene Biotechnology Recent Developments
  109. 12.19 Tsingke
  110. 12.19.1 Tsingke Company Information
  111. 12.19.2 Tsingke Business Overview
  112. 12.19.3 Tsingke Revenue in Site-directed Mutagenesis Service Business (2021-2026)
  113. 12.19.4 Tsingke Site-directed Mutagenesis Service Product Portfolio
  114. 12.19.5 Tsingke Recent Developments
  115. 12.20 AtaGenix
  116. 12.20.1 AtaGenix Company Information
  117. 12.20.2 AtaGenix Business Overview
  118. 12.20.3 AtaGenix Revenue in Site-directed Mutagenesis Service Business (2021-2026)
  119. 12.20.4 AtaGenix Site-directed Mutagenesis Service Product Portfolio
  120. 12.20.5 AtaGenix Recent Developments
  121. 12.21 Zoonbio Biotechnology
  122. 12.21.1 Zoonbio Biotechnology Company Information
  123. 12.21.2 Zoonbio Biotechnology Business Overview
  124. 12.21.3 Zoonbio Biotechnology Revenue in Site-directed Mutagenesis Service Business (2021-2026)
  125. 12.21.4 Zoonbio Biotechnology Site-directed Mutagenesis Service Product Portfolio
  126. 12.21.5 Zoonbio Biotechnology Recent Developments
  127. 12.22 GenScript
  128. 12.22.1 GenScript Company Information
  129. 12.22.2 GenScript Business Overview
  130. 12.22.3 GenScript Revenue in Site-directed Mutagenesis Service Business (2021-2026)
  131. 12.22.4 GenScript Site-directed Mutagenesis Service Product Portfolio
  132. 12.22.5 GenScript Recent Developments
  133. 12.23 Eurofins
  134. 12.23.1 Eurofins Company Information
  135. 12.23.2 Eurofins Business Overview
  136. 12.23.3 Eurofins Revenue in Site-directed Mutagenesis Service Business (2021-2026)
  137. 12.23.4 Eurofins Site-directed Mutagenesis Service Product Portfolio
  138. 12.23.5 Eurofins Recent Developments
  139. 12.24 Applied Biological Materials
  140. 12.24.1 Applied Biological Materials Company Information
  141. 12.24.2 Applied Biological Materials Business Overview
  142. 12.24.3 Applied Biological Materials Revenue in Site-directed Mutagenesis Service Business (2021-2026)
  143. 12.24.4 Applied Biological Materials Site-directed Mutagenesis Service Product Portfolio
  144. 12.24.5 Applied Biological Materials Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst